Eventide Asset Management, LLC
- SEC CIK
- 0001442891
- Latest filing
- Aug 14, 2026
LXEO holding history
Lexeo Therapeutics, Inc. in every 13F filed by Eventide Asset Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LXEO overviewAll 13F holders of LXEOFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q4 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −1,234,834−100.0% | Sold out | Holders |
| Q4 2024 | 1,234,834 | $8.13M | 0.1% | −621,152−33.5% | Reduced | Holders |
| Q3 2024 | 1,855,986 | $16.8M | 0.3% | −1,513,161−44.9% | Reduced | Holders |
| Q2 2024 | 3,369,147 | $54.0M | 0.9% | 00.0% | Unchanged | Holders |
| Q1 2024 | 3,369,147 | $52.8M | 0.8% | +366,316+12.2% | Added | Holders |
| Q4 2023 | 3,002,831 | $40.3M | 0.7% | +3,002,831 | New | Holders |